Sensory-nerve-derived neuropeptides: Possible therapeutic targets

40Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This review examines our developing understanding of the families and activities of some of the best known sensory-nerve-derived inflammatory neuropeptides, namely substance P, calcitonin gene-related peptide and galanin. Evidence to date shows involvement of these transmitters in a wide range of systems that includes roles as inflammatory modulators. There is an increasing understanding of the mechanisms involved in the release of the peptides from sensory nerves and these are key in understanding the potential of neuropeptides in modulating inflammatory responses and may also provide novel targets for anti-inflammatory therapy. The neuropeptides released act via specific G protein coupled receptors, most of which have now been cloned. There is knowledge of selective agonists and antagonists for many subtypes within these families. The study of neuropeptides in animal models has additionally revealed pathophysiological roles that in turn have led to the development of new drugs, based on selective receptor antagonism. © 2009 Springer-Verlag Berlin Heidelberg.

Author supplied keywords

Cite

CITATION STYLE

APA

Fernandes, E. S., Schmidhuber, S. M., & Brain, S. D. (2009). Sensory-nerve-derived neuropeptides: Possible therapeutic targets. Handbook of Experimental Pharmacology. https://doi.org/10.1007/978-3-540-79090-7_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free